SEC Company Response from SELLAS Life Sciences Group, Inc. (SLS) (CIK 0001390478) (SLS) — Jul 11, 2018
SELLAS Life Sciences Group, Inc. (SLS) (CIK 0001390478)
Date: July 11, 2018 · CIK: 0001390478 · Accession: 0001193125-18-215948
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-225140
Letter
Acceleration Request
Cantor Fitzgerald & Co.
Oppenheimer & Co. Inc.
As Representatives of the several Underwriters,
c/o Cantor Fitzgerald & Co.
499 Park Avenue
New York, NY 10022
c/o Oppenheimer & Co. Inc.
85 Broad Street, 26th Floor
New York, NY 10004
VIA EDGAR
July 11, 2018
Ms. Irene Paik
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Re: SELLAS Life Sciences Group, Inc.
Registration Statement on Form S-1
File No. 333-225140
Request for Effectiveness
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended (the “Act”), we, as representatives of the several underwriters, hereby join in the request of SELLAS Life Sciences Group, Inc. (the “Company”) for acceleration of the effective date of the above-named Registration Statement so that it becomes effective at 4:30 PM, Eastern Time, on July 11, 2018, or as soon thereafter as practicable, or at such other time as the Company or its outside counsel, Cooley LLP, request by telephone that such Registration Statement be declared effective.
Pursuant to Rule 460 under the Act, we, as representatives of the several underwriters, wish to advise you that there will be distributed to each underwriter or dealer, who is reasonably anticipated to participate in the distribution of the security, as many copies of the proposed form of preliminary prospectus as appears to be reasonable to secure adequate distribution of the preliminary prospectus.
We, the undersigned, as representatives of the several underwriters, have complied and will comply, and we have been informed by the participating underwriters that they have complied and will comply, with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.
Very truly yours,
CANTOR FITZGERALD & CO.
Show Raw Text
CORRESP 1 filename1.htm Acceleration Request Cantor Fitzgerald & Co. Oppenheimer & Co. Inc. As Representatives of the several Underwriters, c/o Cantor Fitzgerald & Co. 499 Park Avenue New York, NY 10022 c/o Oppenheimer & Co. Inc. 85 Broad Street, 26th Floor New York, NY 10004 VIA EDGAR July 11, 2018 Ms. Irene Paik United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Re: SELLAS Life Sciences Group, Inc. Registration Statement on Form S-1 File No. 333-225140 Request for Effectiveness Ladies and Gentlemen: In accordance with Rule 461 under the Securities Act of 1933, as amended (the “Act”), we, as representatives of the several underwriters, hereby join in the request of SELLAS Life Sciences Group, Inc. (the “Company”) for acceleration of the effective date of the above-named Registration Statement so that it becomes effective at 4:30 PM, Eastern Time, on July 11, 2018, or as soon thereafter as practicable, or at such other time as the Company or its outside counsel, Cooley LLP, request by telephone that such Registration Statement be declared effective. Pursuant to Rule 460 under the Act, we, as representatives of the several underwriters, wish to advise you that there will be distributed to each underwriter or dealer, who is reasonably anticipated to participate in the distribution of the security, as many copies of the proposed form of preliminary prospectus as appears to be reasonable to secure adequate distribution of the preliminary prospectus. We, the undersigned, as representatives of the several underwriters, have complied and will comply, and we have been informed by the participating underwriters that they have complied and will comply, with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended. Very truly yours, CANTOR FITZGERALD & CO. OPPENHEIMER & CO. INC. Acting severally on behalf of themselves and the several Underwriters CANTOR FITZGERALD & CO. By: /s/ Sage Kelley Name: Sage Kelley Title: Head of Investment Banking OPPENHEIMER & CO. INC. By: /s/ Eric Helenek Name: Eric Helenek Title: Managing Director [Signature Page to Underwriters’ Acceleration Request]